Immunity Disorders: Autoimmunity, HIV/AIDS, and Transplant Rejection

By Genie

Introduction to Immunity Disorders

The immune system protects the body against harmful microorganisms and other foreign substances. It relies on a coordinated network of immune cells, antibodies, tissues, and organs to recognize potential threats and regulate the body’s response.

However, immune function does not always work as intended. An excessive immune response can damage healthy tissues, while an inadequate response can leave the body more vulnerable to infections. In some conditions, the immune system mistakenly targets the body’s own tissues.

Understanding these different patterns helps explain several important topics in pathology, including hypersensitivity reactions, autoimmune diseases, immunodeficiency, and transplant rejection.

1. Hypersensitivity Reactions

A hypersensitivity reaction is an immune response that causes tissue injury. Although immune responses normally help protect the body, they can sometimes become excessive or target substances that trigger unnecessary inflammation.

Hypersensitivity reactions are traditionally classified into four major types.

Type I: Immediate Hypersensitivity

Type I hypersensitivity involves immunoglobulin E (IgE) antibodies and immune cells called mast cells. When an allergen triggers this response, mast cells release substances such as histamine, which can cause itching, swelling, sneezing, and other allergic symptoms.

Examples include allergic rhinitis and some forms of food allergy. Severe reactions can cause anaphylaxis, a medical emergency.

Type II: Antibody-Mediated Hypersensitivity

Type II hypersensitivity occurs when antibodies, usually immunoglobulin G (IgG) or immunoglobulin M (IgM), target antigens on cells or tissues. This can lead to cell destruction, inflammation, or changes in cellular function.

Autoimmune hemolytic anemia is one example of a condition involving this mechanism.

Type III: Immune Complex-Mediated Hypersensitivity

Type III hypersensitivity involves immune complexes formed when antibodies bind to antigens. These complexes can accumulate in tissues and activate inflammatory pathways, potentially damaging blood vessels, kidneys, and other structures.

Systemic lupus erythematosus is an important example of a disease in which immune complex formation contributes to tissue injury.

Type IV: T-Cell-Mediated Hypersensitivity

Type IV hypersensitivity is mediated by T lymphocytes rather than antibodies. These immune cells release inflammatory signals or directly damage target cells.

Contact dermatitis caused by substances such as nickel is a familiar example.

Although these four categories are useful for learning, some immune-mediated diseases involve more than one mechanism.

2. Immunologic Tolerance and Autoimmune Diseases

Immunologic tolerance is the ability of the immune system to remain unresponsive to particular antigens under appropriate conditions.

An especially important form is self-tolerance, which helps prevent the immune system from attacking the body’s own healthy cells and tissues.

Self-tolerance develops through several processes. Central tolerance helps eliminate or control self-reactive immune cells as they mature in the thymus or bone marrow. Peripheral tolerance provides additional mechanisms to prevent potentially harmful immune cells from becoming inappropriately activated.

When these protective mechanisms fail, autoimmunity may develop.

An autoimmune disease occurs when the immune system mounts an inappropriate response against the body’s own antigens, known as self-antigens or autoantigens. Autoantibodies may be produced, and self-reactive T cells may contribute to inflammation and tissue damage.

Autoimmune diseases can affect a particular organ or involve multiple systems throughout the body.

Two important examples are systemic lupus erythematosus and rheumatoid arthritis.

3. Systemic Lupus Erythematosus (SLE)

Systemic lupus erythematosus, commonly called SLE or lupus, is a chronic autoimmune disease that can affect multiple organs.

In SLE, the immune system produces antibodies against various self-antigens. Some important targets are components of the cell nucleus. Antibodies can bind to these antigens and form immune complexes, which contribute to inflammation and tissue injury.

Common Clinical Features

SLE can affect different people in different ways. Common manifestations include:

  • Skin rashes and sensitivity to sunlight

  • Joint pain and inflammation

  • Fatigue and fever

  • Blood cell abnormalities, such as anemia or low platelet counts

  • Inflammation of the kidneys

  • Inflammation of the membranes surrounding the lungs or heart

Kidney involvement is particularly important because lupus nephritis can impair kidney function.

Autoantibodies Associated with SLE

Several autoantibodies are useful in evaluating suspected SLE.

Antinuclear Antibodies (ANA) are directed against components of the cell nucleus. They are commonly found in people with SLE, although a positive ANA test alone does not establish the diagnosis.

Anti-double-stranded DNA Antibodies (Anti-dsDNA) are associated with SLE and can be useful when evaluating disease activity and possible kidney involvement.

Anti-Smith Antibodies (Anti-Sm) are relatively specific for SLE, although they are not present in every affected person.

Antiphospholipid antibodies may also occur and are associated with an increased risk of certain blood clots and pregnancy complications.

Factors Associated with SLE

The exact cause of SLE remains incompletely understood. Its development involves interactions among genetic susceptibility, hormonal influences, environmental exposures, and immune regulation.

Genetic factors can increase susceptibility. Hormonal influences may help explain why SLE is more common in women, particularly during the reproductive years.

Ultraviolet radiation can trigger or worsen symptoms in some people. Certain medications can also cause a lupus-like illness, although drug-induced lupus is not identical to every form of SLE.

Overall, SLE illustrates how abnormal immune regulation can lead to inflammation and damage across multiple organ systems.

4. Rheumatoid Arthritis (RA)

Rheumatoid arthritis is a chronic systemic autoimmune disease that primarily affects the joints.

The disease commonly involves the synovium, a tissue that lines the inner surface of movable joints and helps maintain the joint environment.

How Rheumatoid Arthritis Affects the Joints

In RA, immune activity causes persistent inflammation of the synovium, a condition called synovitis.

The inflamed synovial tissue may become thicker and produce inflammatory substances that contribute to damage in nearby structures.

A proliferative inflammatory tissue called pannus may develop. Pannus can invade and damage articular cartilage and the underlying bone.

Over time, this process may lead to joint deformity, reduced mobility, and disability.

Common Clinical Features

Rheumatoid arthritis often affects several joints in a relatively symmetrical pattern, particularly the small joints of the hands and feet.

Common features include:

  • Joint pain and tenderness

  • Swelling and warmth around affected joints

  • Morning stiffness

  • Reduced range of motion

  • Fatigue and general malaise

  • Low-grade fever in some cases

Morning stiffness is a characteristic feature, especially when it lasts for a prolonged period. However, no single symptom is sufficient to diagnose RA.

RA can also affect tissues outside the joints. The disease is therefore considered systemic rather than exclusively a joint condition.

SLE and RA: An Important Distinction

Both SLE and RA are autoimmune diseases, but their typical patterns differ.

SLE can affect the skin, joints, kidneys, blood cells, and serosal membranes. RA primarily causes persistent inflammation of the synovial joints, which can lead to cartilage and bone damage.

These are general patterns rather than absolute rules. Both diseases can produce a range of manifestations, and their clinical presentations may overlap.

5. HIV Infection and AIDS

Human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system, particularly CD4-positive T lymphocytes.

CD4 T cells help coordinate immune responses by communicating with other immune cells. Their loss weakens the body’s ability to respond effectively to certain infections.

How HIV Affects the Immune System

HIV enters susceptible cells and uses its viral replication machinery to produce additional copies of itself. Infection and the resulting immune processes can cause CD4 T-cell loss and impair immune function.

As infection progresses without effective treatment, the immune system may become increasingly compromised.

HIV can also affect other immune cells, including macrophages, and damage the normal organization and function of lymphoid tissues.

What Is AIDS?

Acquired immunodeficiency syndrome (AIDS) is the advanced stage of HIV infection, defined by specific clinical or immunological criteria.

A person with HIV does not necessarily have AIDS. Modern antiretroviral therapy can suppress HIV replication, preserve immune function, and substantially reduce the risk of progression to advanced disease.

Possible Complications

Advanced HIV-related immunodeficiency increases the risk of opportunistic infections, which occur more readily when immune defenses are weakened.

Certain cancers and neurological complications may also occur.

HIV is now a manageable chronic infection for many people receiving effective treatment. Prevention, testing, appropriate medical care, and adherence to prescribed therapy are important components of HIV management.

6. Transplant Rejection

Organ and tissue transplantation can restore or improve function when a person’s own organ or tissue is severely damaged. However, the recipient’s immune system may recognize the transplanted tissue as foreign and mount an immune response against it.

This process is known as transplant rejection.

Why Does Rejection Occur?

The immune system recognizes molecules called antigens. One important group is the major histocompatibility complex (MHC), known as the human leukocyte antigen (HLA) system in humans.

Differences between donor and recipient HLA molecules can contribute to immune recognition of the transplanted tissue.

Transplant rejection may involve both cell-mediated immunity and antibody-mediated immunity.

T-cell-mediated rejection occurs when recipient T cells recognize donor antigens and contribute to tissue injury.

Antibody-mediated rejection occurs when antibodies target antigens associated with the transplanted tissue, potentially causing inflammation and blood vessel damage.

Types of Transplant Rejection

Hyperacute rejection can develop within minutes to hours after transplantation. It is typically associated with pre-existing antibodies that react against the graft.

Acute rejection can occur during the days or months following transplantation, although it may also occur later. It can involve T cells, antibodies, or both.

Chronic rejection develops over a longer period and may involve persistent immune injury, blood vessel changes, fibrosis, and gradual loss of graft function.

These categories describe general patterns. The timing and characteristics of rejection vary according to the transplanted organ, the recipient’s immune status, and the treatment used.

Reducing the Risk of Rejection

Transplant teams use several strategies to reduce the likelihood of rejection, including compatibility testing, HLA assessment, crossmatching, and immunosuppressive medications.

Immunosuppressive therapy reduces harmful immune responses but can also increase susceptibility to infections and other complications. Long-term monitoring is therefore essential.

7. Key Concepts to Remember

The immune system must maintain a balance between protecting the body and avoiding unnecessary tissue damage.

The following concepts summarize the main ideas in this overview:

  • Hypersensitivity: An immune response that causes tissue injury.

  • Immunologic tolerance: The ability to remain unresponsive to specific antigens under appropriate conditions.

  • Autoimmunity: An inappropriate immune response against the body’s own antigens.

  • SLE: A systemic autoimmune disease in which autoantibodies and immune complexes contribute to organ damage.

  • RA: A chronic autoimmune disease characterized by synovial inflammation and potential joint destruction.

  • HIV/AIDS: HIV damages immune function, particularly through the loss of CD4 T cells. AIDS represents advanced HIV-related immunodeficiency.

  • Transplant rejection: Immune-mediated injury to transplanted tissue, involving T cells, antibodies, or both.

Conclusion

Immunity disorders demonstrate that an effective immune system requires more than the ability to recognize and attack foreign substances. It must also regulate the intensity of its responses, maintain tolerance to the body’s own tissues, and coordinate different immune mechanisms.

When these processes become abnormal, the consequences can range from allergic inflammation to systemic autoimmune disease, severe immunodeficiency, or transplant rejection.

Understanding the underlying mechanisms provides a foundation for studying pathology and appreciating how the immune system influences health and disease.

Educational disclaimer: This article is intended for general educational purposes and does not replace professional medical advice, diagnosis, or treatment.